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Abstract We investigated whether adenovirus-mediated pre-
proinsulin gene transfer into insulin target tissues (adipocytes)
ameliorates hyperglycemia in diabetic mice. KKAy mice, a
genetically obese type 2 diabetic animal model, were treated with
a single subcutaneous injection of recombinant adenovirus,
Adex1CA-human preproinsulin (Adex1CA-pchi), into the epidi-
dymal fat pads. pchi mRNA was expressed only in adipose tissue
in which mature insulin was produced. Three days after virus
injection these mice showed a marked decrease of blood glucose
levels (from about 400 to 200 mg/dl), and an intraperitoneal
glucose tolerance test revealed the markedly improved glucose
tolerance. There was no significant difference in serum insulin
levels between control and recombinant adenovirus-treated KKAy
mice. The normalized glucose levels in diabetic mice were
maintained for at least 2 weeks after the virus injection. This
strategy could provide a novel and, most importantly, a simple
and convenient gene therapy for obese type 2 diabetes
patients. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Type 2 diabetes, which a¡ects more than 100 million people
worldwide [1], is caused by a combination of insulin resistance
and a declined capacity of pancreatic L cells [2,3]. One possi-
ble therapeutic strategy for type 2 diabetes would be to con-
struct insulin production and secretory pathways within non-L
cells by transferring the relevant genes and using these cells as
a substitute for L cells. It is essential, however, that the pro-
duction and/or the secretion of insulin in such cells be phys-
iologically regulated. Many research groups have tried to ex-
pand or regenerate pancreatic L cells by genetic engineering
techniques [4] ; however, in most of these trials, a de¢nite way
to regulate insulin secretion from those cells was not estab-
lished [5^8]. In the present study, we took advantage of the
facts that adipocytes characteristically secrete many adipocy-
tokines (e.g. leptin, tumor necrosis factor (TNF)-K, plasmino-
gen activator inhibitor-1) [9] and that the regulated exocytotic
pathway of facilitated glucose transporter 4 (GLUT4) can be
triggered by insulin stimulation [10,11]. We therefore investi-
gated the e¡ect on hyperglycemia of transferring preproinsulin
genes into adipose tissues of obese diabetic KKAy mice.
KKAy mice have genetically determined obesity and diabetic
syndrome [12^14]. These mice show no sexual or seasonal
variation in the appearance of glycosuria, but show hyper-
glycemia and hyperinsulinemia at the age of 5 weeks. The
gene therapy procedure reported here showed some success
in lowering the blood glucose levels of diabetic KKAy mice.
2. Materials and methods
2.1. Recombinant adenovirus
Adenovirus containing human preproinsulin (pchi) cDNA (a gen-
erous gift from Dr. G.I. Bell, University of Chicago), Adex1CA-pchi,
was constructed as described previously [15]. It contains the full length
of pchi cDNA under the control of the modi¢ed chicken L-action
promoter. Adex1w, containing no foreign cDNA, was used as a con-
trol.
2.2. Animal treatments
KKAy mice were obtained from Japan Clea Co. (Tokyo, Japan)
and fed ad libitum. Animals used in the experiments were 10^12 weeks
old, their average weight was 28.8 þ 4.2 g, and blood glucose levels
were s 300 mg/dl. Mice were treated with 0.3 ml of 1U109^5U109
pfu/ml of either Adex1CA-pchi or Adex1w (control) by a single sub-
cutaneous injection into the epididymal fat pads. For another series of
experiments, Zucker fa/fa rats were obtained from Charles River (Yo-
kohama, Japan). Animals used in these experiments were 12 weeks old
and were treated with 2 ml of 1U109 pfu/ml of either Adex1CA-pchi
or Adex1w (control) as described above. 3 days after injection, blood
was drawn from the tail vein to determine glucose concentration.
For the intraperitoneal glucose tolerance test (ipGTT), 6-h-fasted
mice or overnight-fasted rats were intraperitoneally challenged with
2 g/kg body weight glucose, and blood samples were drawn at the
indicated time point from the tail vein. Mice were killed by decapi-
tation, then testis, intestine, lung, liver, skeletal muscle, cardiac
muscle, and epididymal fat pads were rapidly dissected, frozen in liq-
uid nitrogen, and stored at 380‡C until use.
2.3. Reverse transcriptase (RT)-polymerase chain reaction (PCR)
Southern blot analysis
Total tissue RNA was extracted using the acid guanidinium thio-
cyanate^phenol^chloroform method [16]. To detect human insulin
cDNA, RT-PCR was performed as described previously [15]. The
345-bp PCR products were run on a 1.2% agarose gel, transferred
to a nitrocellulose ¢lter, and hybridized with 32P-labeled human in-
sulin cDNA probe as described previously [15].
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2.4. Immunoblot analysis
Immunoblotting was performed as described previously [17].
Brie£y, total proteins from adipose tissues were extracted by sonica-
tion; the proteins were then separated by electrophoresis and trans-
ferred to nitrocellulose membrane ¢lters. Filters were incubated with a
guinea pig anti-insulin antibody (1:1000 dilution), and the bands were
visualized using a chemiluminescence detection system (NEN).
2.5. Immunocytochemistry
3T3L1 cells were grown on coated glass chamber slides (eight wells;
Lab-Tek slides, Nunc), and di¡erentiated to adipocytes by incubation
in medium containing 10% fetal bovine serum (FBS), 1.7 WM insulin,
0.5 mM 3-isobutyl-1-methylxantine, and 1 mM dexamethasone.
3T3L1 adipocytes were infected with Adex1CA-pchi at a multiplicity
of infection of 30 for 1 h in 5% FBS Dulbecco’s modi¢ed Eagle’s
medium; after changing the medium, the cells were cultured for 48 h
and then used for immunocytochemistry. After the slides were washed
several times with KRB containing 110 mM NaCl, 4.4 mM KCl, 1.45
mM KH2PO4, 1.2 mM MgSO4, 2.3 mM Ca gluconate, 4.8 mM
NaHCO3, 2.2 mM glucose, 10 mM HEPES (pH 7.4), and 0.3% bovine
serum albumin, they were ¢xed with 2% paraformaldehyde. The slides
were double-immunostained with rabbit polyclonal anti-GLUT4
(a generous gift from Dr. K. Takata, Gunma University, Gunma,
Japan) and/or monoclonal anti-insulin (Sigma) antibodies, followed
by appropriate second antibodies, and examined by confocal
laser scanning microscopy (Model LSM510, Carl Zeiss Co., Jene,
Germany) at the excitation wavelengths of 488 nm for £uorescein
isothiocyanate (FITC) and 529 nm for rhodamine with a band-pass
¢lter.
2.6. Insulin measurement
Serum insulin levels were measured by enzyme-linked immunosorb-
ent assay (ELISA; MBL, Nagoya, Japan), which reacts with both
mouse and human insulin equally. To detect only human insulin in
mouse serum, we used a human insulin ELISA assay system with
monoclonal anti-human insulin antibody (Dainabot Co., Japan),
which showed less than 2% cross-reactivity with mouse insulin (data
not shown).
2.7. Statistical analysis
Unless stated otherwise, results are means þ S.E.M. from at least
three di¡erent experiments performed independently. Statistical anal-
yses consisted of ANOVA followed by Fisher’s test and regression
analysis using Statview software (Abacus Concepts, Berkeley, CA,
USA).
3. Results and discussion
In the present study, we attempted to take advantage of the
characteristic features of adipocytes as endocrine organs [9].
We hypothesized that if an adipocyte itself secretes insulin via
a regulated vesicle, such as a GLUT4 vesicle, its insulin re-
ceptor could be exposed to high concentrations of released
insulin, and, subsequently, the released insulin may amplify
the insulin action through the endogenous insulin receptor in
an autocrine manner. Indeed, when we infected the 3T3L1
adipocytes with Adex1CA-pchi, (pro)insulin was colocalized
with GLUT4 vesicles (Fig. 1). 3T3L1 adipocytes expressing
human insulin were immunostained with both rabbit poly-
clonal anti-GLUT4 and mouse monoclonal anti-insulin anti-
bodies. Secondary antibodies against rabbit (FITC label) and
mouse (rhodamine label) IgG did not cross-react (data no
shown). As shown in Fig. 1, the yellow color (Fig. 1, merge)
obtained by overlaying the FITC signal (GLUT4) with the
rhodamine signal (insulin) indicated the colocalization of the
expressed (pro)insulin with endogenous GLUT4 in the same
vesicles. Thus, (pro)insulin could be released via the exocyto-
sis of GLUT4 vesicles in response to exogenous insulin stim-
Fig. 1. Colocalization of (pro)insulin and GLUT4 in the same vesicle in a 3T3L1 adipocyte. 3T3L1 adipocytes were infected with Adex1CA-
pchi as described in Section 2. The infected cells were immunostained with rabbit polyclonal anti-GLUT4 and/or mouse monoclonal anti-insulin
antibodies, followed by appropriate second antibodies (GLUT4: FITC; insulin: rhodamine), and observed by confocal laser scanning microsco-
py. The yellow color (merge) obtained after overlaying FITC (GLUT4) and rhodamine (insulin) indicates the colocalization of (pro)insulin and
GLUT4 in the same vesicle. Bar = 10 Wm.
Fig. 2. Preproinsulin mRNA and protein expression in epididymal
fat pads of KKAy mice treated with recombinant adenovirus.
KKAy mice were treated with a single subcutaneous injection of 0.3
ml of 1U109^5U109 pfu/ml Adex1CA-pchi into the epididymal fat
pads. A: Preproinsulin mRNA detected by RT-PCR Southern blot
analysis. 3 days after the virus injection, epididymal fat pads, testis,
liver, lung, intestine, skeletal muscle, and cardiac muscle were re-
moved, and processed for RNA isolation. The cDNAs were reverse-
transcribed from total RNAs and subjected to the PCR; PCR prod-
ucts were separated by 1.2% agarose gel electrophoresis, blotted
onto a nitrocellulose ¢lter, and hybridized with 32P-labeled human
insulin cDNA probe. A representative autoradiograph of three sepa-
rate experiments is shown: (1) epididymal fat pads; (2) testis; (3) in-
testine; (4) lung; (5) liver; (6) skeletal muscle; (7) cardiac muscle;
(8) negative control. B: Proinsulin and insulin expression in adipose
tissues. Total protein was extracted from adipose tissues of recombi-
nant adenovirus-treated KKAy mice and subjected to immunoblot
analysis with guinea pig anti-insulin antibody. Protein bands were
detected by a chemiluminescent detection system.
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ulation by a mechanism in which insulin-receptor signaling
causes the movement of GLUT4 vesicles from the intracellu-
lar pool to the plasma membrane [18].
We investigated the e¡ect on blood glucose levels of ex-
pressing the preproinsulin gene in adipose tissues in KKAy
mice, an animal model for obese type 2 diabetes [12^14].
We infected adipose tissues of KKAy mice with recombinant
adenovirus, Adex1CA-pchi or Adex1w (control), by a single
subcutaneous injection into the epididymal fat pads. RT-PCR
Southern blot analysis revealed that preproinsulin mRNA was
expressed in adipose tissues of the mice treated with Adex1-
CA-pchi, but not in surrounding tissues such as testis and
intestine (Fig. 2A). We also did not observe any mRNA ex-
pression in liver, lung, skeletal muscle, or cardiac muscle. Fig.
2B clearly shows the immunoblot protein band of proinsulin
and insulin in the adipose tissues. Although proinsulin-con-
verting enzymes PC2 and PC3 are not expressed in adipocytes,
furin expressed in adipocytes (data not shown) can process
proinsulin to mature insulin, although with low e⁄ciency
[19]. The introduction of furin-cleavable consensus sequence
into pchi may cause the e⁄cient conversion of proinsulin to
insulin in adipose tissue. Thus, in adenovirus-injected adipose
tissues of KKAy mice, pchi gene was expressed and eventually
mature insulin was produced.
Three days after adenovirus injection into adipose tissues of
KKAy mice, we measured blood glucose levels in fed animals.
As shown in Fig. 3A, KKAy mice treated with Adex1CA-pchi
showed a decrease in blood glucose levels (202 þ 20.4 mg/dl,
P6 0.001 versus Adex1w [control] group: 391 þ 27 mg/dl).
There was no signi¢cant change of serum insulin levels be-
tween Adex1w- (control) and Adex1CA-pchi-treated KKAy
mice. In addition, the serum level of immunoreactive human
insulin (measured by human insulin ELISA) was very low in
Adex1CA-pchi-treated KKAy mice (about 70 pg/ml; Fig. 3B),
indicating that the decrease in blood glucose levels is due to
an autocrine e¡ect in the adipose tissues. Because adipose
tissue is a relatively minor glucose disposal site in the body,
however, mechanisms other than the proposed autocrine loop
are also possible. The plasma levels of free fatty acids [20],
leptin [21,22], TNF-K [23,24], and resistin [25] released from
adipose tissues play a role in regulating glucose metabolism,
and the expression of human insulin gene in adipose tissues
may a¡ect these parameters. We are currently investigating
these possibilities.
Results of the ipGTT showed a gradual decrease in blood
glucose levels in Adex1CA-pchi-treated KKAy mice (Fig. 3C).
It is noteworthy that the marked drop of blood glucose levels
was observed at 90 and 120 min after glucose loading (90
min: 281 þ 41 versus 412 þ 33 mg/dl, P6 0.001; 120 min:
223 þ 41 versus 396 þ 28 mg/dl, P6 0.001). Because this sys-
tem is switched on only after insulin released from pancreatic
L cells binds to the endogenous insulin receptor on adipocytes
harboring the preproinsulin gene, it cannot reduce the blood
glucose level immediately after glucose loading. A potential
advantage of this system, however, is that sustained hyper-
glycemia may be suppressed without causing hypoglycemia,
because the secretion of adipocyte insulin is indirectly regu-
lated by blood glucose levels, as mentioned above. When con-
sidering the use of this gene therapy in humans, this observa-
tion is critical for practical application. An eventual decrease
in blood glucose levels as shown by ipGTT indicates that local
Fig. 3. Blood glucose level, insulin level, and ipGTT of mice treated with recombinant adenovirus. KKAy mice were fed ad libitum until the
ages of 8^12 weeks. These mice were treated with 0.3 ml of 1U109^5U109 pfu/ml of Adex1CA-pchi or Adex1w (control) by a single subcutane-
ous injection into the region of the epididymal fat. A: Blood glucose levels: random blood samples were taken from tail veins of fed mice
3 days after injection with recombinant adenoviruses. Blood glucose levels were signi¢cantly lower in KKAy mice treated with Adex1CA-pchi
than those treated with Adex1w (control mice, n = 10; KKAy mice treated with Adex1w, n = 6; KKAy mice treated with Adex1CA-pchi, n = 4).
B: Serum insulin levels. Serum insulin levels were measured by ELISA using blood samples taken 3 days after virus injection. Open column
shows serum insulin levels containing mouse and human insulin, and solid column shows only human insulin levels measured by human insulin
ELISA system. C: ipGTT. After mice were fasted for 6 h, glucose (2 g/kg body weight) was injected intraperitoneally; blood samples were
then collected at the indicated time intervals from the tail vein (n = 4). *P6 0.01, **P6 0.05, ***P6 0.001 versus Adex1CA-pchi-treated mice.
Fig. 4. Glucose tolerance test of Zucker fa/fa rats treated with
Adex1CA-pchi. Zucker fa/fa rats (12 weeks old) were treated with
2 ml of 5U109 pfu/ml of Adex1CA-pchi or Adex1w (control) by a
single subcutaneous injection into the region of the epididymal fat
pads. After rats were fasted overnight, ipGTT was performed as de-
scribed in the legend of Fig. 3. Data represent the mean of two ex-
periments.
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exposure of extremely high concentrations of insulin, which is
exocytosed via an initial GLUT4 translocation after glucose
loading, accelerates the glucose uptake.
Our failure to reduce the rapid increase of glucose level
after glucose loading may be due to impaired GLUT4 trans-
location, which might be caused by GLUT4 down-regulation
in adipocytes of diabetic, insulin-resistant mice [26]. It is
known that insulin sensitivity of adipose tissue in KKAy
mice decreases with age [13] ; however, at the age of 10^12
weeks, the insulin-resistant status in adipose tissue is still in-
complete. Abdominal administration of insulin (2 U/kg)
markedly decreased the blood glucose levels from 400 to
100^200 mg/dl in KKAy mice (unpublished results). KKAy
mice (9 weeks old) pretreated with the analog of thiazolidine
showed a marked drop of blood glucose levels by insulin
administration (0.5 U/kg, i.p.) [27]. Thus, at this age the in-
sulin signal in adipose tissue is expected to be still, but not
completely, intact in KKAy mice. To examine the e¡ect of this
procedure on another animal model, we injected 2 ml of
Adex1CA-pchi into epididymal fat pads of obese Zucker fa/
fa rats. 2 days after virus injection, we performed an ipGTT.
Fig. 4 shows that the impaired glucose tolerance observed in
fa/fa rats was slightly improved by Adex1CA-pchi treatment.
Finally, we examined the time course of blood glucose lev-
els in Adex1CA-pchi-treated KKAy mice. The lowered blood
glucose levels were maintained for at least 2 weeks after the
virus injection. Adex1CA-pchi-treated mice showed lower
blood glucose levels (from approximately 400 to about 150
mg/dl) from 2 days after virus treatment until 2 weeks after
receiving recombinant adenovirus (Fig. 5). Although some
researchers have reported that adenovirus-transferred gene ex-
pression was sustained for up to 15 months [28], we found
that the blood glucose levels were back to 400 mg/dl only
1 month after virus injection, which is consistent with the
disappearance of human insulin gene expression in the virus-
injected region (data not shown). We propose that proper
glucose levels are maintained via mutual communication be-
tween pancreatic L cells and adipocytes (Fig. 6).
Although the precise mechanism underlying this system
must still be determined by in vitro experiments, which we
are currently pursuing, we emphasize the bene¢cial e¡ects
and advantages of this therapeutic system. This gene therapy
is very simple and convenient, particularly for the treatment
of obese type 2 diabetes. Obese diabetic patients could easily
subcutaneously inject the virus into their abdominal fat, po-
tentially controlling glucose levels.
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